DrugPatentWatch Database Preview
Details for Patent: 8,668,929
» See Plans and Pricing
Which drugs does patent 8,668,929 protect, and when does it expire?
Patent 8,668,929 protects XARTEMIS XR and is included in one NDA.
This patent has nine patent family members in eight countries.
Summary for Patent: 8,668,929
| Title: | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| Abstract: | Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("GI") of a mammal for an extended period of time. |
| Inventor(s): | Han; Chien-Hsuan (Sunnyvale, CA), Hou; Sui Yuen Eddie (Foster City, CA), Reid; Monica L. (San Mateo, CA) |
| Assignee: | Depomed, Inc. (Newark, CA) |
| Application Number: | 13/529,960 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,668,929 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 8,668,929
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Inc | XARTEMIS XR | acetaminophen; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 204031-001 | Mar 11, 2014 | DISCN | Yes | No | Start Trial | Start Trial | MANAGEMENT OF ACUTE PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,668,929
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009223061 | Start Trial | |||
| Canada | 2720108 | Start Trial | |||
| China | 102105136 | Start Trial | |||
| European Patent Office | 2262484 | Start Trial | |||
| Hong Kong | 1152469 | Start Trial | |||
| Japan | 2011513499 | Start Trial | |||
| Japan | 5607550 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
